Human Papilloma Virus (HPV) and Host Cellular Interactions

Overview

Journal Pathol Oncol Res

Specialty Oncology

Date 2008 May 22

PMID 18493868

Citations 28

Authors

Ioannis N Mammas

George Sourvinos

Athena Giannoudis

Demetrios A Spandidos

Affiliations

Soon will be listed here.

Abstract

Viral-induced carcinogenesis has been attributed to the ability of viral oncoproteins to target and interact with the host cellular proteins. It is generally accepted that Human papilloma virus (HPV) E6 and E7 function as the dominant oncoproteins of 'high-risk' HPVs by altering the function of critical cellular proteins. Initially it was shown that HPV E6 enhances the degradation of p53, while HPV E7 inactivates the function of the retinoblastoma tumor suppressor protein Rb. However, recent studies during the last decade have identified a number of additional host cellular targets of both HPV E6 and E7 that may also play an important role in malignant cellular transformation. In this review we present the interactions of HPV E6 and E7 with the host cellular target proteins. We also present the role of DNA integration in the malignant transformation of the epithelial cell.

Citing Articles

The role of extracellular vesicles in the pathogenesis of gynecological cancer.

Chatterjee M, Gupta S, Mukherjee T, Parashar D, Kumar U, Maitra A Front Oncol. 2024; 14:1477610.

PMID: 39391238 PMC: 11464257. DOI: 10.3389/fonc.2024.1477610.

An updated systemic review and meta-analysis on human papillomavirus in breast carcinogenesis.

Awan U, Khattak A, Ahmed N, Guo X, Akhtar S, Kamran S Front Oncol. 2023; 13:1219161.

PMID: 37711194 PMC: 10498127. DOI: 10.3389/fonc.2023.1219161.

Role of stress in the pathogenesis of cancer (Review).

Lempesis I, Georgakopoulou V, Papalexis P, Chrousos G, Spandidos D Int J Oncol. 2023; 63(5).

PMID: 37711028 PMC: 10552722. DOI: 10.3892/ijo.2023.5572.

Critical involvement of circular RNAs in virus-associated cancers.

Zebardast A, Latifi T, Shirzad M, Goodarzi G, Fana S, Tehrani S Genes Dis. 2023; 10(6):2296-2305.

PMID: 37554189 PMC: 10404876. DOI: 10.1016/j.gendis.2022.04.009.

Novel Variant Identified in the Enhancer Region of Host Transcription Factor, BRN3A, is a Significant Risk Factor for HPV-Induced Uterine Cervix Cancer.

Prakash A, Das Purkayastha B, Srivastava S, Chaturvedi S, Ali A, Dayal Aggarwal D Int J Mol Cell Med. 2023; 11(2):88-103.

PMID: 37091039 PMC: 10116355. DOI: 10.22088/IJMCM.BUMS.11.2.88.

References

Giannoudis A, Duin M, Snijders P, Herrington C . Variation in the E2-binding domain of HPV 16 is associated with high-grade squamous intraepithelial lesions of the cervix. Br J Cancer. 2001; 84(8):1058-63. PMC: 2363853. DOI: 10.1054/bjoc.2001.1695. View

Zerfass K, Schulze A, Spitkovsky D, FRIEDMAN V, Henglein B, Jansen-Durr P . Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J Virol. 1995; 69(10):6389-99. PMC: 189538. DOI: 10.1128/JVI.69.10.6389-6399.1995. View

Huibregtse J, Scheffner M, Howley P . Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol Cell Biol. 1993; 13(8):4918-27. PMC: 360130. DOI: 10.1128/mcb.13.8.4918-4927.1993. View

Heck D, Yee C, Howley P, Munger K . Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc Natl Acad Sci U S A. 1992; 89(10):4442-6. PMC: 49098. DOI: 10.1073/pnas.89.10.4442. View

Steben M, Duarte-Franco E . Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol. 2007; 107(2 Suppl 1):S2-5. DOI: 10.1016/j.ygyno.2007.07.067. View

Arroyo M, Bagchi S, Raychaudhuri P . Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex. Mol Cell Biol. 1993; 13(10):6537-46. PMC: 364713. DOI: 10.1128/mcb.13.10.6537-6546.1993. View

Turner C . Paxillin interactions. J Cell Sci. 2000; 113 Pt 23:4139-40. DOI: 10.1242/jcs.113.23.4139. View

Lee S, Kim J, Lee H, Cho Y, Oh S, Kim Y . Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-gamma induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression. Oncogene. 2003; 22(3):381-91. DOI: 10.1038/sj.onc.1206133. View

Gao Q, Kumar A, Singh L, Huibregtse J, Beaudenon S, Srinivasan S . Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase. Cancer Res. 2002; 62(11):3315-21. View

10.

Thomas M, Banks L . Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene. 1999; 17(23):2943-54. DOI: 10.1038/sj.onc.1202223. View

11.

Barnard P, McMillan N . The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha. Virology. 1999; 259(2):305-13. DOI: 10.1006/viro.1999.9771. View

12.

Chen J, Reid C, Band V, Androphy E . Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science. 1995; 269(5223):529-31. DOI: 10.1126/science.7624774. View

13.

Alazawi W, Pett M, Arch B, Scott L, Freeman T, Stanley M . Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16. Cancer Res. 2002; 62(23):6959-65. View

14.

Ronco L, Karpova A, Vidal M, Howley P . Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 1998; 12(13):2061-72. PMC: 316980. DOI: 10.1101/gad.12.13.2061. View

15.

Holt S, Shay J, Wright W . Refining the telomere-telomerase hypothesis of aging and cancer. Nat Biotechnol. 1996; 14(7):836-9. DOI: 10.1038/nbt0796-836. View

16.

Peter M, Rosty C, Couturier J, Radvanyi F, Teshima H, Sastre-Garau X . MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors. Oncogene. 2006; 25(44):5985-93. DOI: 10.1038/sj.onc.1209625. View

17.

Bruce J, Hurford Jr R, Classon M, Koh J, Dyson N . Requirements for cell cycle arrest by p16INK4a. Mol Cell. 2000; 6(3):737-42. DOI: 10.1016/s1097-2765(00)00072-1. View

18.

Lee S, Glaunsinger B, Mantovani F, Banks L, Javier R . Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J Virol. 2000; 74(20):9680-93. PMC: 112400. DOI: 10.1128/jvi.74.20.9680-9693.2000. View

19.

Scheffner M, Huibregtse J, Vierstra R, Howley P . The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 1993; 75(3):495-505. DOI: 10.1016/0092-8674(93)90384-3. View

20.

Handa K, Yugawa T, Narisawa-Saito M, Ohno S, Fujita M, Kiyono T . E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein. J Virol. 2006; 81(3):1379-89. PMC: 1797514. DOI: 10.1128/JVI.01712-06. View